Published in J Virol on January 01, 1989
Packaging capacity and stability of human adenovirus type 5 vectors. J Virol (1993) 2.76
Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci U S A (1989) 2.74
Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport. J Virol (1989) 1.53
A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer. J Virol (2010) 1.43
Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model. Proc Natl Acad Sci U S A (1992) 1.15
Armed replicating adenoviruses for cancer virotherapy. Cancer Gene Ther (2009) 1.13
Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport. Proc Natl Acad Sci U S A (1996) 1.10
Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutant. J Virol (1992) 1.03
Correction of a deletion mutant by gene targeting with an adenovirus vector. Mol Cell Biol (1993) 0.97
Recombinant feline herpesviruses expressing feline leukemia virus envelope and gag proteins. J Virol (1990) 0.92
Studies on the stability of a human adenovirus-rabies recombinant vaccine. Can J Vet Res (1992) 0.78
Efficient trapping of HIV-1 envelope protein by hetero-oligomerization with an N-helix chimera. Retrovirology (2005) 0.76
Expression of the OSU rotavirus outer capsid protein VP4 by an adenovirus recombinant. J Virol (1992) 0.75
Expression of the extracellular domain of the human immunodeficiency virus type 1 envelope protein and its fusion with beta-galactosidase in Saccharomyces cerevisiae. Clin Diagn Lab Immunol (1998) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (1984) 33.32
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science (1984) 32.33
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (1986) 22.26
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57
Nucleotide sequence of the AIDS virus, LAV. Cell (1985) 16.81
Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science (1984) 15.82
Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science (1984) 11.30
Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (1986) 10.62
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature (1986) 8.36
Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. J Immunol (1985) 7.35
HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science (1986) 6.33
AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science (1986) 5.58
Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science (1985) 5.42
Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J Virol (1987) 5.03
Definition and mapping of adenovirus 2 nuclear transcription. Methods Enzymol (1980) 3.67
Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus. J Virol (1986) 3.64
Generation of adenovirus by transfection of plasmids. Nucleic Acids Res (1983) 3.33
Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. Nature (1986) 3.19
Human adenoviruses: growth, purification, and transfection assay. Methods Enzymol (1979) 2.06
Expression of AIDS virus envelope gene in recombinant vaccinia viruses. Nature (1986) 1.98
Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J Virol (1985) 1.88
HTLV-III env gene products synthesized in E. coli are recognized by antibodies present in the sera of AIDS patients. Cell (1985) 1.87
Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus. Virology (1976) 1.73
A new animal model for human respiratory tract disease due to adenovirus. J Infect Dis (1984) 1.71
Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. Proc Natl Acad Sci U S A (1987) 1.70
Identification of adenovirus genes that require template replication for expression. J Virol (1983) 1.59
Immunoprevention of Friend virus-induced erythroleukemia by vaccination with viral envelope glycoprotein complexes. Virology (1981) 1.43
Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome. Proc Natl Acad Sci U S A (1986) 1.40
Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral GP71 glycoprotein and its corresponding antiserum. Virology (1975) 1.37
Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proc Natl Acad Sci U S A (1987) 1.31
Detection and characterization of the protein encoded by the v-rel oncogene. Virology (1986) 1.30
Prevention of simian acquired immune deficiency syndrome with a formalin-inactivated type D retrovirus vaccine. J Virol (1986) 1.24
Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1987) 1.14
Construction of adenovirus expression vectors by site-directed in vivo recombination. J Mol Appl Genet (1982) 1.12
Genetic analysis of mRNA synthesis in adenovirus region E3 at different stages of productive infection by RNA-processing mutants. J Virol (1986) 1.10
Expression of envelope glycoproteins of human immunodeficiency virus by an insect virus vector. J Virol (1987) 1.02
Mechanism of inhibition of vaccinia virus replication in adenovirus-infected HeLa cells. J Virol (1971) 1.01
Active immunization with feline leukemia virus envelope glycoprotein suppresses growth of virus-induced feline sarcoma. Med Microbiol Immunol (1983) 1.00
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science (1989) 7.90
Structure of replicating simian virus 40 deoxyribonucleic acid molecules. J Virol (1971) 6.74
Origin and direction of simian virus 40 deoxyribonucleic acid replication. J Virol (1972) 6.39
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A (1999) 5.25
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med (1995) 4.06
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. J Virol (1997) 3.64
Intermediate in SV40 DNA chain growth. Nat New Biol (1972) 3.38
Resolutions and identification of the core deoxynucleoproteins of the simian virus 40. Biochem Biophys Res Commun (1973) 2.90
Sequential protein synthesis following vaccinia virus infection. J Virol (1968) 2.89
Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med (1990) 2.65
Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals. J Virol (1989) 2.62
Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis (1994) 2.60
Inhibition in the joining of DNA intermediates to growing simian virus 40 chains. J Virol (1973) 2.44
JC virus enhancer-promoter active in human brain cells. Science (1984) 2.36
Sequential formation of vaccinia virus proteins and viral deoxyribonucleic acid replication. J Virol (1967) 2.34
Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNA. Cell (1982) 2.32
Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection. Mol Biol Evol (1999) 2.32
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A (2000) 2.20
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection. Blood (2000) 2.15
HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy. Lancet (1999) 2.13
Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy. J Infect Dis (2000) 1.96
Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge. Clin Exp Allergy (2007) 1.94
Simian virus 40 major late promoter: an upstream DNA sequence required for efficient in vitro transcription. Mol Cell Biol (1984) 1.94
N-acylated glycerophospholipids and their derivatives. Prog Lipid Res (1990) 1.77
Metabolic properties of early and late vaccinia virus messenger ribonucleic acid. J Virol (1967) 1.70
Specific initiation site for simian virus 40 deoxyribonucleic acid replication. J Virol (1972) 1.66
NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. J Neurosci (2009) 1.65
Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda. HIV Med (2007) 1.58
Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport. J Virol (1989) 1.53
Simian virus 40 guanine-cytosine-rich sequences function as independent transcriptional control elements in vitro. Mol Cell Biol (1984) 1.52
Involvement of c-Src in diperoxovanadate-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol (2000) 1.51
The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol (1991) 1.51
Envelope-specific antibodies in the saliva of individuals vaccinated with recombinant HIV-1 gp160. J Acquir Immune Defic Syndr (1992) 1.49
Expression of protein kinase C isozymes in nonpregnant and pregnant human myometrium. Am J Obstet Gynecol (2000) 1.46
Unwinding of parental strands during simian virus 40 DNA replication. J Virol (1973) 1.43
The SV40 DNA template for transcription of late mRNA in viral nucleoprotein complexes. Cell (1977) 1.42
Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats. J Lab Clin Med (1996) 1.41
Characterization of Simian virus 40 DNA component II during viral DNA replication. J Mol Biol (1973) 1.40
Molecular cloning and predicted full-length amino acid sequence of the type I beta isozyme of cGMP-dependent protein kinase from human placenta. Tissue distribution and developmental changes in rat. FEBS Lett (1989) 1.39
Biochemical changes in phytohemagglutinin stimulated human lymphocytes. Exp Cell Res (1966) 1.39
In vitro transcription initiation by purified RNA polymerase II within the adenovirus 2 major late promoter region. J Biol Chem (1984) 1.38
Occurrence and properties of a chromatin-associated F1-histone phosphokinase in mitotic Chinese hamster cells. Biochemistry (1972) 1.38
Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 and comparison of the test with enzyme-linked immunosorbent assay and Western blot (immunoblot) analysis. J Clin Microbiol (1989) 1.36
The N-acylation-phosphodiesterase pathway and cell signalling. Chem Phys Lipids (1996) 1.35
Superhelix density of replicating simian virus 40 DNA molecules. J Mol Biol (1974) 1.34
Interstitial hyperosmolarity may cause axis cylinder shrinkage in streptozotocin diabetic nerve. J Neuropathol Exp Neurol (1980) 1.31
Chemical modification of simian virus 40 DNA by reaction with a water-soluble carbodiimide. J Virol (1976) 1.31
Proximal and distal domains that control in vitro transcription of the adenovirus IVa2 gene. Proc Natl Acad Sci U S A (1984) 1.30
Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitors. Virology (1992) 1.29
Mapping of transcription sites of simian virus 40-specific late 16S and 19S mRNA by electron microscopy. Proc Natl Acad Sci U S A (1977) 1.28
N-Acylethanolamine accumulation in infarcted myocardium. Biochem Biophys Res Commun (1979) 1.27
Characterization of the human gene encoding the type I alpha and type I beta cGMP-dependent protein kinase (PRKG1). Genomics (1997) 1.27
Factors involved in specific transcription by mammalian RNA polymerase II. Role of factors IID and MLTF in transcription from the adenovirus major late and IVa2 promoters. J Biol Chem (1989) 1.26
Regulation of endothelial cell myosin light chain kinase by Rho, cortactin, and p60(src). Am J Physiol (1999) 1.26
Properties of simian virus 40 transcriptional intermediates isolated from nuclei of permissive cells. J Virol (1977) 1.25
Persistence of four related human immunodeficiency virus subtypes during the course of zidovudine therapy: relationship between virion RNA and proviral DNA. J Virol (1994) 1.25
Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor. Cell Signal (2007) 1.24
Efficient transcription of a compact nucleoprotein complex isolated from purified simian virus 40 virions. J Virol (1980) 1.21
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults. Nat Med (1998) 1.21
Studies of polyoma virus DNA: cleavage map of the polyoma virus genome. J Virol (1975) 1.20
Characterization of simian virus 40 tsA58 transcriptional intermediates at restrictive temperatures: relationship between DNA replication and transcription. J Virol (1977) 1.20
Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. J Biol Chem (1983) 1.20
Regulation of simian virus 40 early and late gene transcription without viral DNA replication. J Virol (1979) 1.14
Separation of isolated Chinese hamster metaphase chromosomes into three size-groups. J Mol Biol (1968) 1.14
Mapping 5' termini of JC virus late RNA. J Virol (1986) 1.13
N-Acylation of ethanolamine phospholipids in canine myocardium. Biochim Biophys Acta (1982) 1.12
Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium. Biochim Biophys Acta (1980) 1.12
F1-histone modification at metaphase in Chinese hamster cells. Exp Cell Res (1972) 1.11
Synthetic analogs of FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] differentially regulate pulmonary vascular permeability in vivo and in vitro. J Pharmacol Exp Ther (2009) 1.11
Characterization of the 5'-terminal structure of simian virus 40 early mRNA's. J Virol (1979) 1.10
Hin D restriction mapping of upaired regions in simian virus 40 superhelical DNA I: considerations regarding structure-function relationships. J Virol (1976) 1.10
Preferential stimulation of transcription from simian virus 40 late and adeno IVa2 promoters in a HeLa cell extract. J Biol Chem (1983) 1.08
Diperoxovanadate alters endothelial cell focal contacts and barrier function: role of tyrosine phosphorylation. J Appl Physiol (1985) (2000) 1.07
Catabolism of N-acylethanolamine phospholipids by dog brain preparations. J Neurochem (1984) 1.05
Late replicative intermediates are accumulated during simian virus 40 DNA replication in vivo and in vitro. J Virol (1979) 1.03
Characterization of a surrogate TATA box promoter that regulates in vitro transcription of the simian virus 40 major late gene. Mol Cell Biol (1985) 1.03
Selective degradation of newly synthesized nonmessenger simian virus 40 transcripts. J Virol (1978) 1.03
Significantly reduced radiation exposure to operators during kyphoplasty and vertebroplasty procedures: methods and techniques. AJNR Am J Neuroradiol (2006) 1.03
Simian virus 40 DNA replication: characterization of gaps in the termination region. J Virol (1976) 1.02
Properties of replicating SV40 DNA molecules and mapping unpaired regions in SV40 DNA I. Cold Spring Harb Symp Quant Biol (1975) 1.02
Self-annealing of 4 S strands from replicating simian virus 40 DNA. J Mol Biol (1973) 1.02
Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. Am J Physiol (1999) 1.01
Interferon-alpha produces significant decreases in HIV load. J Interferon Cytokine Res (2010) 0.99
Adenovirus-2 E1a and E1b gene products regulate enhancer mediated transcription. Nucleic Acids Res (1986) 0.99
N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain. Biochim Biophys Acta (1986) 0.98
Sociological aspects of child labour. Indian J Pediatr (1985) 0.97
The relationship of SV40 replicating chromosomes to two forms of the non-replicating SV40. Nucleic Acids Res (1978) 0.97
Activation of protein phosphorylation by oxidants in vascular endothelial cells: identification of tyrosine phosphorylation of caveolin. Free Radic Biol Med (1997) 0.96
Positive and negative control sequences within the distal domain of the adenovirus IVa2 promoter overlap with the major late promoter. J Virol (1985) 0.96